CIK 0001840233
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851623397
- Phone
- +1 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- 4 Planned sale SVP, FINANCE AND ACCOUNTING sold 1,803 shares at $0.98 ($1,774)
- 4 Option exercise PRESIDENT AND CEO acquired 44,250 shares (option exercise)
- 4 Open-market buy 10% owner bought 1,759,978 shares at $1.04 ($1,830,377)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 8 · 150 filings